<DOC>
	<DOC>NCT00701090</DOC>
	<brief_summary>A study to see if better control of type 2 diabetes can occur in patients taking a stable dose of metformin when they are also provided either sitagliptin or glimepiride. This study will also see if this treatment is safe and tolerable.</brief_summary>
	<brief_title>A Study to Test the Safety and Efficacy of Sitagliptin Compared to Glimepiride in Patients With Type 2 Diabetes on a Stable Dose of Metformin (0431-803)(COMPLETED)</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Glimepiride</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>18 years or older Diagnosed with type 2 diabetes On a stable dose of metformin of at least 1500 mg per day History of type 1 diabetes Pregnant HIV positive On a weight loss program or medication Has a history of blood disorder, certain cancers, heart, liver or kidney disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Type 2 Diabetes Mellitus</keyword>
	<keyword>Non Insulin Dependent</keyword>
</DOC>